To include your compound in the COVID-19 Resource Center, submit it here.
TECHNOLOGY: Plasma markers
Serum levels of IL-6 and MCP-1 could help predict the risk of neurologic adverse
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury